Trial
NCT03801499
Lenvatinib for Unresectable Intrahepatic Cholangiocarcinoma
Phase IIWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
Sun Yat-sen University
Collaborators
—
Condition
Intrahepatic Cholangiocarcinoma
Intervention
Lenvatinib
Why stopped
Protocol modification
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2020-05-21